ATE214935T1 - Robinia pseudoacacia lektin und seine verwendungen - Google Patents

Robinia pseudoacacia lektin und seine verwendungen

Info

Publication number
ATE214935T1
ATE214935T1 AT98940437T AT98940437T ATE214935T1 AT E214935 T1 ATE214935 T1 AT E214935T1 AT 98940437 T AT98940437 T AT 98940437T AT 98940437 T AT98940437 T AT 98940437T AT E214935 T1 ATE214935 T1 AT E214935T1
Authority
AT
Austria
Prior art keywords
robinia pseudoacacia
lectin
pseudoacacia lectin
robinia
disease
Prior art date
Application number
AT98940437T
Other languages
English (en)
Inventor
Arpad Janos Pusztai
Zsuszanna Magdolna Ow Bardocz
Richard Michael John Palmer
Neil William Fish
Original Assignee
Alizyme Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd
Application granted granted Critical
Publication of ATE214935T1 publication Critical patent/ATE214935T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT98940437T 1997-08-29 1998-08-28 Robinia pseudoacacia lektin und seine verwendungen ATE214935T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718413.9A GB9718413D0 (en) 1997-08-29 1997-08-29 Compositions
PCT/GB1998/002612 WO1999011278A1 (en) 1997-08-29 1998-08-28 Robinia pseudoacacia lectin and its uses

Publications (1)

Publication Number Publication Date
ATE214935T1 true ATE214935T1 (de) 2002-04-15

Family

ID=10818276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940437T ATE214935T1 (de) 1997-08-29 1998-08-28 Robinia pseudoacacia lektin und seine verwendungen

Country Status (13)

Country Link
EP (1) EP1009418B1 (de)
JP (1) JP2001514230A (de)
CN (1) CN1170587C (de)
AT (1) ATE214935T1 (de)
AU (1) AU740353B2 (de)
CA (1) CA2301848A1 (de)
DE (1) DE69804466T2 (de)
ES (1) ES2175752T3 (de)
GB (1) GB9718413D0 (de)
HU (1) HU225762B1 (de)
NZ (1) NZ502971A (de)
RU (1) RU2214259C2 (de)
WO (1) WO1999011278A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6310195B1 (en) 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US6991794B1 (en) 1997-06-24 2006-01-31 Imclone Systems Incorporated Progenitor cell preservation factors and methods for and products of their use
KR100473422B1 (ko) * 2003-06-12 2005-03-14 박원봉 렉틴 함유 천연물의 장용성 코팅용 조성물
EP2218456B1 (de) * 2009-02-10 2011-03-16 Helvista AG Lektinzusammensetzung zur Prophylaxe und/oder Behandlung von unerwünschten Arzneimittelnebenwirkungen
DE102010033458B4 (de) 2010-08-05 2016-03-10 Helvista Ag Emulgierte Lektinzusammensetzungen und ihre Verwendung
KR101836679B1 (ko) 2015-08-19 2018-04-20 중앙대학교 산학협력단 아까시나무 잎 추출물을 유효성분으로 함유하는 ＩＬ－１β 관련 질환 예방 또는 치료용 약학조성물
RU2746424C1 (ru) * 2019-11-05 2021-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования «Астраханский государственный медицинский университет» Министерства здравоохранения Российской Федерации Способ выделения лектина бобов солодки гладкой
CN117858717A (zh) * 2021-08-30 2024-04-09 联合化学实验室有限公司 用于治疗炎症性疾病的蛋白质组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280432A (ja) * 1985-06-05 1986-12-11 Asahi Chem Ind Co Ltd 抗腫瘍免疫細胞誘導方法
RU1799599C (ru) * 1990-11-16 1993-03-07 Львовский государственный медицинский институт Способ получени лектина

Also Published As

Publication number Publication date
DE69804466D1 (de) 2002-05-02
JP2001514230A (ja) 2001-09-11
GB9718413D0 (en) 1997-11-05
WO1999011278A1 (en) 1999-03-11
AU740353B2 (en) 2001-11-01
CN1170587C (zh) 2004-10-13
HUP0003537A3 (en) 2002-01-28
CA2301848A1 (en) 1999-03-11
DE69804466T2 (de) 2002-11-14
HU225762B1 (en) 2007-08-28
EP1009418B1 (de) 2002-03-27
AU8876398A (en) 1999-03-22
NZ502971A (en) 2003-02-28
RU2214259C2 (ru) 2003-10-20
CN1273533A (zh) 2000-11-15
ES2175752T3 (es) 2002-11-16
EP1009418A1 (de) 2000-06-21
HUP0003537A2 (hu) 2001-02-28

Similar Documents

Publication Publication Date Title
IT1276783B1 (it) Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
DE60229431D1 (de) Verwendungen von chitosanoligosacchariden
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
EP1040830A4 (de) Heilmittel für neurodegenerative krankheiten
AU2002351593A1 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
DE60108325D1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
DE60012301D1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
WO2002052954A3 (en) Nutritional composition for a bone condition
DK0951909T4 (da) Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
AU5225498A (en) Biaromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
ATE214935T1 (de) Robinia pseudoacacia lektin und seine verwendungen
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
NO20016004D0 (no) Sammensetning som innbefatter alkalin-sfingomyelinase for anvendelse som et kostholdspreparat, n¶ringsmiddeltilskudd ellerfarmasöytisk produkt
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
BG105275A (en) Tan-1057 derivatives
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
MXPA02011465A (es) Sal de creatina que tiene eficacia terapeutica y nutricional mejorada y composiciones que contienen la misma.
ZA200501714B (en) Analogues of vitamin d
AU2379997A (en) Remedy for external application, and use of an oil-in-water emulsion for said remedy
AU2003290031A1 (en) Method of improvement of blood circulation
ATE404519T1 (de) Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen
ITRM20010494A0 (it) Integratore dietetico per la cura e la prevenzione della miopia.
BR0300548A (pt) Composição, medicamento, medicamento para a profilaxia ou terapia da pancreatite, suplemento alimentar, alimento de cuidado da saúde, ração, e, método para produzir a composição
AU2003271442A1 (en) Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
ITRM20010493A0 (it) Integratore dietetico per la cura e la prevenzione della degenerazione maculare.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties